Lishan International Biopharma Manufacturing Base is a center for high-end medical and pharmaceutical production in Lixia. [Photo/WeChat account: lixiakonggu]

In the heart of Shandong, a powerful wave of life science innovation is reshaping Jinan's industrial landscape. At the center of this transformation is the Lixia Economic Development Zone, where the Changlingshan biopharma cluster has quickly grown from vision to reality. The signing of Shandong Xinbo Pharmaceutical Research Co Ltd in February 2024 marked a milestone for both the company and the region. After searching multiple cities, Xinbo found its ideal location in the Lishan International Cell Medicine Industrial Park, drawn by its advanced facilities, supportive ecosystem, and seamless integration with nearby research platforms.

The cluster now comprises three complementary parks – Lishan Cell Medicine Industrial Park, Biopharma Manufacturing Base, and Phase II of the Cell Medicine Park – tailored to companies in different stages. Over 60 high-quality enterprises, including listed firms and national high-tech leaders, have already settled in. Backed by the newly approved Lixia Economic Development Zone, the area is quickly becoming a magnet for innovation and industrial synergy.

Today, with nearly 100 biopharma companies and institutions, Changlingshan is advancing towards becoming a national hub for biomedical excellence—where talent, innovation, and enterprise thrive together.